Canna Law Blog

MARCH 11, 2024

First introduced in 2023, HB 1453 sought to harmonize the existing medical exemptions from general sales and use taxes with the 37% excise tax on cannabis sales. Primarily, medical cannabis is not recreational or a luxury, but a necessity for many people who suffer from chronic pain, epilepsy, PTSD, and other conditions.

Chronic Pain 104

Chronic Pain Recreational Patients Medicine 104

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Veriheal

DECEMBER 22, 2022

Andy Beshear (Democratic Party) outlined a list of conditions that state residents must meet to access medicinal-grade cannabis starting on Jan. “Rather than sidestep the policy-making branch and violate the Constitution, I invite him to work with us to develop a legal medical marijuana program.” ” Lt.

THC 62

THC Conditions Policy Packaging 62

The Blunt Truth

JULY 5, 2023

Starting August 1, 2023, Minnesota will provide protections to individuals who use cannabis for recreational purposes, after Minnesota Governor Tim Walz signed a state law allowing adults 21 and older to use recreational cannabis. What about random, reasonable suspicion, post-accident, and treatment program testing for cannabis?

Law 52

Law Recreational Policy Treatment 52

SpeedWeed

SEPTEMBER 13, 2021

“The time required to grow the plants, which will be raised in greenhouses, is 90 to 110 days,” AL.com noted, adding that unless the September 2022 application date is modified, “products could not be available until some time in 2023.”. Furthermore, we reject the notion that cannabis should be a treatment of ‘last resort.’

Cultivation 90

Cultivation Marijuana Treatment Legislation 90

Cannabis Law Report

FEBRUARY 16, 2022

— A new treatment option is on the way for Oregonians. It’s called psilocybin — more commonly referred to as magic mushrooms — and it will be available to health care providers starting in 2023. . The use of psilocybin is meant to help treat conditions like depression, PTSD, addiction, severe anxiety, and more.

Programs 52

Programs Treatment Policy Conditions 52

Veriheal

FEBRUARY 17, 2023

1, 2023, Gov. Beshear’s executive order allows Kentuckians with specific conditions the right to use medical cannabis. Beshear was quoted saying, “Kentuckians suffering from chronic and terminal conditions are going to be able to get the treatment they need without living in fear of a misdemeanor. As of Jan.

Marijuana 84

Marijuana Conditions Legalization Treatment 84

Veriheal

NOVEMBER 6, 2020

A “Yes on Measure 110” campaign that helped bring awareness to this effort was funded by the Drug Policy Alliance, an advocacy group based out of New York. He goes on to ask the question, “How many people are going to actually be offered treatment?”. million between 2021-2023 alone, with this number increasing over time.

Decriminalization 76

Decriminalization Treatment Advocacy Policy 76

SpeedWeed

APRIL 22, 2021

“It has been scientifically proven that medical marijuana has a considerable impact in treating conditions common with veterans when they return from service, like chronic pain and PTSD,” said Rep. To fund the research and policy changes, the bill would allocate $15 million in federal funding from the 2022 and 2023 fiscal budgets.

Chronic Pain 52

Chronic Pain Legalization Treatment Conditions 52

Cannabis Law Report

JANUARY 27, 2022

The task force will complete a study and provide policy recommendations that will serve as a basis for substantive policy reforms during the 2023 legislative session. Policy Considerations for the Task Force. Task Force Members. The Psilocybin Equity task force currently calls for 14 members.

Research and Development 52

Research and Development Policy Access Legislation 52

The Blunt Truth

AUGUST 22, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or. Next Steps for Employers.

Safety 111

Safety Environment Policy Recreational 111

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. estimates that 60-70% of his patients are seeking out medical cannabis for the treatment of chronic pain.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

Veriheal

MARCH 29, 2023

However, a 2023 study debunks many myths about the potential dangers of legalizing cannabis. In some cases, legalization policies only allowed home-grown cannabis or had not yet implemented commercial sales. Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Legalization 57

Legalization Data Policy Cannabis 57

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. Those who can afford to sacrifice medical program benefits to consistently access medical cannabis treatment will be fine. .’s Medical Cannabis Program. The act expands existing D.C. These changes to D.C.’s

Patients 97

Patients Programs Access Treatment 97

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

SEPTEMBER 22, 2022

Still before Governor Newsom for his signature is SB 1496 , which would implement a series of changes to the state’s cannabis tax policy, including authorizing regulators to extend the deadline for tax payments by cannabis businesses located in areas affected by an emergency proclamation by the Governor. FOOTNOTES. [1] Source: [link].

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

AUGUST 23, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or. Next Steps for Employers.

Safety 52

Safety Environment Policy Recreational 52

Cannabis Law Report

JUNE 23, 2022

Kathy Hochul announced June 22 the selection of Social Equity Impact Ventures LLC, a minority-led investment team, to sponsor and manage New York’s $200-million Social Equity Cannabis Investment Program that was included in the state’s fiscal 2023 enacted state budget. ” Social Equity Cannabis Investment Fund.

Seed-To-Sale 52

Seed-To-Sale Programs Retail Dispensary 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Defining Psychedelics. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 21, 2022

Existing law requires employers to test a prospective employee for marijuana only after extending a conditional offer of employment. employers should review their policies and training to ensure they are prepared to satisfy these requirements. The new law does not speak to random or return-to-work testing.

Recreational 52

Recreational Safety Programs Patients 52

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105